chr2-47798625-C-T

Variant summary

Our verdict is Likely benign.
-3 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -3 classification points (ACGS-UK Somatic Oncogenicity v2025). O4_SupportingB1_Strong

The ENST00000434234.6(FBXO11):n.*125-9185G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. Note: ENST00000434234.6 is not a MANE Select or MANE Plus Clinical transcript for FBXO11; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The gene FBXO11 is a tumor suppressor gene (CancerMine: 9 TSG, 8 oncogene citations). The gene FBXO11 is a known oncogene (CancerMine: 9 TSG, 8 oncogene citations). The variant allele was found at a cumulative frequency of 0.0912 (AC=146,849) in the gnomAD database across 1,610,204 control chromosomes, including 7,851 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.107. In-silico predictor (AlphaMissense) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★★). The variant has been observed in cBioPortal in 5 samples across 4 studies and 4 cancer types; somatic enrichment level: SUPPORTING (Observed repeatedly in cBioPortal somatic datasets.).

Frequency

Genomes: 𝑓 0.072 ( 550 hom., cov: 32)
Exomes 𝑓: 0.093 ( 7301 hom. )

Consequence

FBXO11
ENST00000434234.6 intron

Scores

4

Clinical Significance

Benign reviewed by expert panel B:25

Conservation

PhyloP100: -2.00

Publications

39 publications found
Variant links:
Genes affected
MSH6 (HGNC:7329): (mutS homolog 6) This gene encodes a member of the DNA mismatch repair MutS family. In E. coli, the MutS protein helps in the recognition of mismatched nucleotides prior to their repair. A highly conserved region of approximately 150 aa, called the Walker-A adenine nucleotide binding motif, exists in MutS homologs. The encoded protein heterodimerizes with MSH2 to form a mismatch recognition complex that functions as a bidirectional molecular switch that exchanges ADP and ATP as DNA mismatches are bound and dissociated. Mutations in this gene may be associated with hereditary nonpolyposis colon cancer, colorectal cancer, and endometrial cancer. Transcripts variants encoding different isoforms have been described. [provided by RefSeq, Jul 2013]
MSH6 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
  • Lynch syndrome 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
FBXO11 (HGNC:13590): (F-box protein 11) This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. It can function as an arginine methyltransferase that symmetrically dimethylates arginine residues, and it acts as an adaptor protein to mediate the neddylation of p53, which leads to the suppression of p53 function. This gene is known to be down-regulated in melanocytes from patients with vitiligo, a skin disorder that results in depigmentation. Polymorphisms in this gene are associated with chronic otitis media with effusion and recurrent otitis media (COME/ROM), a hearing loss disorder, and the knockout of the homologous mouse gene results in the deaf mouse mutant Jeff (Jf), a single gene model of otitis media. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jun 2010]
FBXO11 Gene-Disease associations (from GenCC):
  • intellectual developmental disorder with dysmorphic facies and behavioral abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000434234.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -3 points.

O4Enriched in somatic variant database
Enriched in cBioPortal (pre-computed score ≥ 1.0) — Supporting (O4); cBioPortal: samples=5 | studies=4 | cancer types=4 | level=SUPPORTING | points=1.0 | reason: Observed repeatedly in cBioPortal somatic datasets.
B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.107 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: ENST00000434234.6. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

MSH6 NM_000179.3
MANE Select
HGVSc / HGVSpc.642C>Tp.Tyr214Tyr
Exon rankExon 4 of 10
synonymous
Prot: NP_000170.1UniProt: P52701-1
MSH6 NM_001281493.2
HGVSc / HGVSpc.-265C>T
Exon rankExon 3 of 9
5_prime_UTR_premature_start_codon_gain
Prot: NP_001268422.1UniProt: P52701-4
MSH6 NM_001281494.2
HGVSc / HGVSpc.-265C>T
Exon rankExon 4 of 10
5_prime_UTR_premature_start_codon_gain
Prot: NP_001268423.1UniProt: P52701-4

Ensembl Transcripts

MSH6 ENST00000234420.11
TSL:1MANE Select
HGVSc / HGVSpc.642C>Tp.Tyr214Tyr
Exon rankExon 4 of 10
synonymous
Prot: ENSP00000234420.5UniProt: P52701-1
MSH6 ENST00000445503.5
TSL:1
HGVSc / HGVSpn.472C>T
Exon rankExon 3 of 9
non_coding_transcript_exon
Prot: ENSP00000405294.1UniProt: F8WAX8
MSH6 ENST00000936511.1
HGVSc / HGVSpc.642C>Tp.Tyr214Tyr
Exon rankExon 4 of 10
synonymous
Prot: ENSP00000606570.1UniProt: A0ACI8TYH3
MSH6 ENST00000700002.1
HGVSc / HGVSpc.648C>Tp.Tyr216Tyr
Exon rankExon 4 of 10
synonymous
Prot: ENSP00000514750.1UniProt: A0A8V8TQJ0
MSH6 ENST00000895687.1
HGVSc / HGVSpc.642C>Tp.Tyr214Tyr
Exon rankExon 4 of 11
synonymous
Prot: ENSP00000565746.1UniProt: P52701-1
MSH6 ENST00000936508.1
HGVSc / HGVSpc.642C>Tp.Tyr214Tyr
Exon rankExon 4 of 10
synonymous
Prot: ENSP00000606567.1UniProt: A0ACI8TXW4
MSH6 ENST00000936509.1
HGVSc / HGVSpc.642C>Tp.Tyr214Tyr
Exon rankExon 4 of 10
synonymous
Prot: ENSP00000606568.1UniProt: A0ACI8TY03
MSH6 ENST00000411819.2
TSL:4
HGVSc / HGVSpc.345C>Tp.Tyr115Tyr
Exon rankExon 4 of 10
synonymous
Prot: ENSP00000406248.2UniProt: A0A494C0M1
MSH6 ENST00000420813.6
TSL:4
HGVSc / HGVSpc.345C>Tp.Tyr115Tyr
Exon rankExon 4 of 10
synonymous
Prot: ENSP00000390382.2UniProt: A0A494C0M1
MSH6 ENST00000455383.6
TSL:5
HGVSc / HGVSpc.345C>Tp.Tyr115Tyr
Exon rankExon 4 of 10
synonymous
Prot: ENSP00000397484.2UniProt: A0A494C0M1
MSH6 ENST00000652107.1
HGVSc / HGVSpc.345C>Tp.Tyr115Tyr
Exon rankExon 6 of 12
synonymous
Prot: ENSP00000498629.1UniProt: A0A494C0M1
MSH6 ENST00000673637.1
HGVSc / HGVSpc.345C>Tp.Tyr115Tyr
Exon rankExon 4 of 10
synonymous
Prot: ENSP00000501310.1UniProt: A0A494C0M1
MSH6 ENST00000700004.2
HGVSc / HGVSpc.642C>Tp.Tyr214Tyr
Exon rankExon 4 of 8
synonymous
Prot: ENSP00000514752.2UniProt: A0A8V8TQW9
MSH6 ENST00000540021.6
TSL:2
HGVSc / HGVSpc.252C>Tp.Tyr84Tyr
Exon rankExon 2 of 8
synonymous
Prot: ENSP00000446475.1UniProt: P52701-3
MSH6 ENST00000700000.1
HGVSc / HGVSpc.642C>Tp.Tyr214Tyr
Exon rankExon 4 of 10
synonymous
Prot: ENSP00000514749.1UniProt: A0A8V8TPJ4
MSH6 ENST00000895688.1
HGVSc / HGVSpc.628-1213C>T
Exon rankIntron 3 of 9
intron
Prot: ENSP00000565747.1UniProt: A0ACI8QWG9
MSH6 ENST00000895689.1
HGVSc / HGVSpc.628-2041C>T
Exon rankIntron 3 of 9
intron
Prot: ENSP00000565748.1UniProt: A0ACI8RLM0
MSH6 ENST00000895690.1
HGVSc / HGVSpc.458-4795C>T
Exon rankIntron 2 of 7
intron
Prot: ENSP00000565749.1UniProt: A0ACI8S2F0
MSH6 ENST00000936510.1
HGVSc / HGVSpc.627+2562C>T
Exon rankIntron 3 of 7
intron
Prot: ENSP00000606569.1UniProt: A0ACI8TY01
FBXO11 ENST00000405808.6
TSL:5
HGVSc / HGVSpc.179-9185G>A
Exon rankIntron 3 of 3
intron
Prot: ENSP00000385127.2UniProt: B5MCV6
MSH6 ENST00000456246.1
TSL:3
HGVSc / HGVSpn.*130C>T
Exon rankExon 3 of 3
3_prime_UTR
Prot: ENSP00000410570.1UniProt: F8W7G9
MSH6 ENST00000456246.1
TSL:3
HGVSc / HGVSpn.*130C>T
Exon rankExon 3 of 3
non_coding_transcript_exon
Prot: ENSP00000410570.1UniProt: F8W7G9
MSH6 ENST00000673922.1
HGVSc / HGVSpn.364C>T
Exon rankExon 2 of 2
non_coding_transcript_exon
Prot:
MSH6 ENST00000699999.1
HGVSc / HGVSpn.726C>T
Exon rankExon 4 of 9
non_coding_transcript_exon
Prot:
FBXO11 ENST00000434234.6
TSL:3
HGVSc / HGVSpn.*125-9185G>A
Exon rankIntron 3 of 3
intron
Prot: ENSP00000402692.2UniProt: E7EP88
MSH6 ENST00000700003.1
HGVSc / HGVSpn.627+2562C>T
Exon rankIntron 3 of 8
intron
Prot: ENSP00000514751.1UniProt: A0A8V8TPR2
MSH6 ENST00000700001.1
HGVSc / HGVSpn.*202C>T
Exon rankN/A
downstream_gene
Prot:

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.0719
AC:10921
Hom:550
AN:151930
Cov:32
GnomAD2 exomes
AF: 0.0711
AC:17523
AN:246622
GnomAD4 exome
AF: 0.0932
AC:135926
Hom:7301
AN:1458156
Cov:34
GnomAD4 genome
AF: 0.0718
AC:10923
Hom:550
AN:152048
Cov:32
TOPMed (Bravo)
AF: 0.0614
AC:16263
Hom:721
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0794
AC:14375
Hom:760
AN:180950
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.0615
AC:144
Hom:2
AN:2342
ChinaMAP Phase 1
AF: 0.000542
Denmark Genome
AF: 0.0867
AC:26
AN:300
ESP6500 (Exome Variant Server)
AF: 0.0691
AC:899
AN:13006
GenomeAsia100K
AF: 0.00924
AC:32
AN:3478
Korea4K (4,157 Koreans)
AF: 0.000276
AC:2
AN:7234
Qatari Genome
AF: 0.0103
AC:20
AN:1946
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.000114
AC:14
Hom:0
AN:122624
Turkish Variome
AF: 0.0325
AC:216
Hom:1
AN:6650
UK10K
AF: 0.104
AC:787
AN:7562
Showing 16 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.114 *126811104 0.124 *218317616
BipEx
(Bipolar disorder (including schizoaffective))
0.114 324428420 0.113 326528844
Epi25
(Epilepsy)
0.0845 354641958 0.0852 570166888
SCHEMA
(Schizophrenia)
0.0710 8895125210 0.0830 16643200434
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
5
Lynch syndrome 5 (5)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
3
not provided (3)
-
-
2
Lynch syndrome (2)
-
-
1
Carcinoma of colon (1)
-
-
1
Endometrial carcinoma;C1833477:Lynch syndrome 5;C5436807:Mismatch repair cancer syndrome 3 (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)

Computational Scores

AlphaGenome AVI
Benign0.036
AlphaMissense
Benign0.25
BayesDel_noAF
Benign-0.82
CADD
Benign0.23
DANN
Benign0.92
GPN-Star LLR
N/A1.6
GPN-Star score
N/A1.6
Mutation Taster
N/A299/1polymorphism (auto)
PhyloP100
Benign-2.0
RBP_binding_hub_radar
N/A1.1
RBP_regulation_power_radar
N/A2.2
Showing 11 of 11 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs1800937;
hg19: chr2-48025764;
COSMIC: COSV52279626;
COSMIC: COSV52279626;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.